These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23578538)

  • 1. Physical symptoms, coping styles and quality of life in recurrent ovarian cancer: a prospective population-based study over the last year of life.
    Price MA; Bell ML; Sommeijer DW; Friedlander M; Stockler MR; Defazio A; Webb PM; ; ; Butow PN
    Gynecol Oncol; 2013 Jul; 130(1):162-8. PubMed ID: 23578538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hopelessness and complementary therapy use in patients with ovarian cancer.
    Gross AH; Cromwell J; Fonteyn M; Matulonis UA; Hayman LL
    Cancer Nurs; 2013; 36(4):256-64. PubMed ID: 23086133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life in ovarian cancer patients receiving chemotherapy.
    Lakusta CM; Atkinson MJ; Robinson JW; Nation J; Taenzer PA; Campo MG
    Gynecol Oncol; 2001 Jun; 81(3):490-5. PubMed ID: 11371144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canadian women's perspectives on ovarian cancer.
    Fitch MI; Gray RE; DePetrillo D; Franssen E; Howell D
    Cancer Prev Control; 1999 Feb; 3(1):52-60. PubMed ID: 10474753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coping with recurrent breast cancer: predictors of distressing symptoms and health-related quality of life.
    Kenne Sarenmalm E; Ohlén J; Jonsson T; Gaston-Johansson F
    J Pain Symptom Manage; 2007 Jul; 34(1):24-39. PubMed ID: 17544244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience and predictors of symptoms, distress and health-related quality of life over time in postmenopausal women with recurrent breast cancer.
    Kenne Sarenmalm E; Ohlén J; Odén A; Gaston-Johansson F
    Psychooncology; 2008 May; 17(5):497-505. PubMed ID: 17886259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mediating role of appraisal and coping in the relationship between optimism-pessimism and quality of life.
    Schou I; Ekeberg Ø; Ruland CM
    Psychooncology; 2005 Sep; 14(9):718-27. PubMed ID: 15669084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical activity in women with ovarian cancer and its association with decreased distress and improved quality of life.
    Beesley VL; Price MA; Butow PN; Green AC; Olsen CM; ; ; Webb PM
    Psychooncology; 2011 Nov; 20(11):1161-9. PubMed ID: 20740686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caring for women with ovarian cancer in the last year of life: a longitudinal study of caregiver quality of life, distress and unmet needs.
    Butow PN; Price MA; Bell ML; Webb PM; deFazio A; ; ; Friedlander M
    Gynecol Oncol; 2014 Mar; 132(3):690-7. PubMed ID: 24423880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active coping mediates the association between religion/spirituality and quality of life in ovarian cancer.
    Canada AL; Parker PA; de Moor JS; Basen-Engquist K; Ramondetta LM; Cohen L
    Gynecol Oncol; 2006 Apr; 101(1):102-7. PubMed ID: 16256181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of issues surrounding quality of life among women with ovarian cancer.
    Arriba LN; Fader AN; Frasure HE; von Gruenigen VE
    Gynecol Oncol; 2010 Nov; 119(2):390-6. PubMed ID: 20594586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and predictors of insomnia in women with invasive ovarian cancer: anxiety a major factor.
    Price MA; Zachariae R; Butow PN; deFazio A; Chauhan D; Espie CA; Friedlander M; Webb PM; ;
    Eur J Cancer; 2009 Dec; 45(18):3262-70. PubMed ID: 19540748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of psychological and behavioral variables in quality of life and the experience of bodily pain among persons living with HIV.
    Kowal J; Overduin LY; Balfour L; Tasca GA; Corace K; Cameron DW
    J Pain Symptom Manage; 2008 Sep; 36(3):247-58. PubMed ID: 18411016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal assessment of quality of life in ovarian cancer patients.
    Penar-Zadarko B; Binkowska-Bury M; Wolan M; Gawelko J; Urbanski K
    Eur J Oncol Nurs; 2013 Jun; 17(3):381-5. PubMed ID: 23200482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life in patients with human immunodeficiency virus infection: impact of social support, coping style and hopelessness.
    Swindells S; Mohr J; Justis JC; Berman S; Squier C; Wagener MM; Singh N
    Int J STD AIDS; 1999 Jun; 10(6):383-91. PubMed ID: 10414881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective assessment of quality of life in ovarian cancer patients receiving whole abdomen hyperthermia and liposomal doxorubicin.
    Hahn CA; Jones EL; Blivin JL; Sanders LL; Yu D; Dewhirst MW; Secord AA; Prosnitz LR
    Int J Hyperthermia; 2005 Jun; 21(4):349-57. PubMed ID: 16019860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychiatric disorders following first breast cancer recurrence: prevalence, associated factors and relationship to quality of life.
    Okamura M; Yamawaki S; Akechi T; Taniguchi K; Uchitomi Y
    Jpn J Clin Oncol; 2005 Jun; 35(6):302-9. PubMed ID: 15961434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychosocial morbidity of Graves' orbitopathy.
    Kahaly GJ; Petrak F; Hardt J; Pitz S; Egle UT
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):395-402. PubMed ID: 16181231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helplessness/hopelessness, minimization and optimism predict survival in women with invasive ovarian cancer: a role for targeted support during initial treatment decision-making?
    Price MA; Butow PN; Bell ML; deFazio A; Friedlander M; Fardell JE; Protani MM; Webb PM;
    Support Care Cancer; 2016 Jun; 24(6):2627-34. PubMed ID: 26732767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OVQUEST - Life after the diagnosis and treatment of ovarian cancer - An international survey of symptoms and concerns in ovarian cancer survivors.
    Webber K; Carolus E; Mileshkin L; Sommeijer D; McAlpine J; Bladgen S; Coleman RL; Herzog TJ; Sehouli J; Nasser S; Inci G; Friedlander M
    Gynecol Oncol; 2019 Oct; 155(1):126-134. PubMed ID: 31416612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.